|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-02
|
$712,729
|
$712,729
|
BASU, HIRAK
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Yale SPORE in Skin Cancer
|
5P50CA121974-09
|
$2,185,000
|
$262,200
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung
|
1P50CA196530-01
|
$2,185,000
|
$764,750
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
$30,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
$624,001
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
$5,240
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$218,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Whole Genome Amplification and Sequencing of Single Cancer Cells
|
5R33CA174560-03
|
$419,521
|
$419,521
|
XIE, XIAOLIANG SUNNEY
|
HARVARD UNIVERSITY
|
|
VHL tumor suppressor gene and the initiation of renal cell carcinoma
|
5R01CA109860-11
|
$328,499
|
$328,499
|
HSU, TIEN
|
BOSTON MEDICAL CENTER
|
|
Vesicular stomatitis VSVrp30 selectively destroys human metastatic melanoma
|
5R01CA161048-04
|
$345,488
|
$345,488
|
VAN DEN POL, ANTHONY
|
YALE UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
1R01CA194404-01
|
$332,363
|
$332,363
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vermont PROSPR Research Center (VPRC)
|
3U54CA163303-05S1
|
$53,851
|
$2,693
|
SPRAGUE, BRIAN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Vermont PROSPR Research Center (VPRC)
|
5U54CA163303-05
|
$1,072,210
|
$53,611
|
SPRAGUE, BRIAN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VEGF Signaling in Mammary Tumorigenesis
|
5R01CA168464-04
|
$347,563
|
$173,782
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Vascular mechanisms regulating breast cancer brain metastasis
|
5R01CA170140-04
|
$357,419
|
$357,419
|
ELICEIRI, BRIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vascular communication in metastatic brain colonization
|
5R01CA184594-02
|
$321,625
|
$321,625
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$1,085,551
|
$325,665
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Validation of, and therapeutic evaluation in ovarian cancer GEM models
|
ZIA BC 011353
|
$172,904
|
$34,581
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer
|
1R01CA195493-01
|
$254,873
|
$50,975
|
MORRIS, EVAN
|
YALE UNIVERSITY
|
|
Validation of Genomic Targets in Melanoma
|
5R01CA114337-11
|
$312,281
|
$312,281
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
5P01CA154291-04
|
$3,698,322
|
$776,648
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$5,614
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$18,750
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$643,274
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing HuR to optimize the treatment of pancreatic cancer
|
5R21CA182692-02
|
$168,563
|
$55,626
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$24,139
|
$16,898
|
Merlino, Glenn
|
CCR (NCI)
|
|
Use of aAPC for Melanoma Adoptive Immunotherapy
|
5R01CA108835-10
|
$318,780
|
$318,780
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
$9,375
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
$7,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$934,677
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297
|
3U54CA096297-13S2
|
$152,250
|
$51,765
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-13S1
|
$110,195
|
$37,466
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-13S3
|
$198,411
|
$67,460
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
5U54CA096297-13
|
$1,553,790
|
$528,289
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
|
1R01CA190642-01A1
|
$436,922
|
$218,461
|
BASELGA, JOSE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-29S1
|
$89,185
|
$32,998
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-29
|
$1,485,000
|
$549,450
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support Grant
|
2P30CA118100-11
|
$1,900,889
|
$57,027
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S1
|
$113,250
|
$3,398
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S2
|
$50,000
|
$1,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S3
|
$250,000
|
$7,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S4
|
$125,000
|
$3,750
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S5
|
$172,654
|
$5,180
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-27S1
|
$198,450
|
$29,768
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-27
|
$6,097,616
|
$914,642
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$90,982
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$28,742
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$15,718
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$46,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$353,050
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
Total relevant funding to Metastasis for this search: $384,561,391
|